The #1 most cited and #1 largest open-access journal in Immunology
Frontiers in Immunology is a peer-reviewed Open Access Journal, and the official Journal of the International Union of Immunological Societies (IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large.
Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans.
All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.
Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.
Frontiers in Immunology is a member of the Committee on Publication Ethics.
Short Name: Front. Immunol.
Electronic ISSN: 1664-3224
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef
PMCID: all published articles receive a PMCID
Frontiers in Immunology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Immunology welcome submission of the following article types: Case Report, Classification, Clinical Study Protocol, Clinical Trial, Correction, Editorial, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Technology Report, General Commentary, Protocols, Specialty Grand Challenge, Systematic Review, Book Review, Data Report, Addendum and Erratum.
When submitting a manuscript to Frontiers in Immunology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Immunology.